APOGEM CAPITAL LLC BioCryst Pharmaceuticals, Inc. Transaction History

APOGEM CAPITAL LLC portfolio value:

$0
portfolio value

APOGEM CAPITAL LLC quarter portfolio value change:

+19.09%
quarter

BioCryst Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -13.21K shares -140K $12.6 0
Q2 2022 share Increase 0.00% 13.21K shares 140K $10.58 13.21K